October 15, 2014 — Veterinary CyberKnife Cancer Center (VC3), a privately owned advanced radiation treatment center for veterinary use, today announced the opening of its facility in Malvern, Pa. The CyberKnife is a non-invasive way to deliver radiation to tumors, enabling treatment with greater precision than traditional linear accelerators and intensity modulated radiation therapy (IMRT) machines. The CyberKnife delivers an entire therapeutic dose of radiation in one to three treatments versus 17 to 20 treatments of traditional radiation therapy. VC3 has changed the way companion animals with cancerous tumors are treated.
CyberKnife (manufactured by Accuray Inc. of Sunnyvale, Calif.), is also called stereotactic radiosurgery. It utilizes a sophisticated robotic arm that revolves around the animal, delivering precisely targeted radiation to the tumor while sparing healthy tissue and surrounding organs. The precision of the CyberKnife allows tumors that haven’t historically been treated with radiation in the veterinary field, such as lung and liver tumors, to be treated. The end result is more precise and far fewer treatments, a significantly reduced number of anesthetic episodes, fewer visits to the veterinarian and a better quality of life for the pet and owner.
“The CyberKnife offers the best clinical option for the majority of my patients undergoing palliative or definitive radiation treatment,” said Siobhan Haney, DVM., M.S., DACVR (RO), MBA. Haney is a veterinary radiation oncologist at Hope Veterinary Specialists in Malvern, Pa.
VC3 owns and operates one of only two CyberKnifes in the world devoted for veterinary use and the only CyberKnife for veterinary use in the Mid-Atlantic region.
For more information: www.vetcyberknife.com
March 28, 2024 
